Julie R Ingelfinger. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Albuminuria/prevention & controlAngiotensin II Type 1 Receptor Blockers/adverse effectsAngiotensin II Type 1 Receptor Blockers/therapeutic useBlood Pressure/drug effectsCardiovascular Diseases/chemically inducedCardiovascular Diseases/mortalityDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyHumansImidazoles/adverse effectsImidazoles/therapeutic useTetrazoles/adverse effectsTetrazoles/therapeutic use
Substances: See more » Angiotensin II Type 1 Receptor BlockersImidazolesTetrazolesolmesartan
Year: 2011 PMID: 21388316 DOI: 10.1056/NEJMe1014147
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245